Watson Next Target As Purdue Protects Insomnia Drug Patent
Purdue Pharmaceutical Products LP on Monday expanded its efforts to protect its insomnia treatment Intermezzo, leveling a new patent infringement suit against Watson Pharmaceuticals Inc. in New Jersey federal court....To view the full article, register now.
Already a subscriber? Click here to view full article